Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Mar 27, 2014
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Award
Common Stock
2014-03-25−3,864→ 10,465 total - Award
Stock option (right to buy)
2014-03-25+10,070→ 10,070 totalExercise: $3.30From: 2014-03-25Exp: 2024-03-25→ Common Stock (10,070 underlying) - Tax Payment
Common Stock
2014-03-25$3.30/sh−2,783$9,184→ 6,601 total
Holdings
- 12,491(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 6,190 performance shares, which represent the portion of the Reporting Person?s 2012 performance share award.
- [F2]Shares have been adjusted to reflect the issuer?s 1-for-8 reverse split effectuated on July 15, 2013.
- [F3]Award of Restricted Stock Units under the issuer?s 2013 Stock Option and Incentive Plan that vest immediately on 03/25/2014.
- [F4]Not applicable.
- [F5]The stock option vests immediately on 03/25/2014.